700 patients110,866 observations180 daysLIVE
← Patients

Patient P-02492

Synthetic patientMETA-24 · Day 146 · 25–34 · M · baseline S20Steering view · 3DOpen companion preview
Therapy response
Unstable
Tolerance
Favorable
GI state
Favorable
Inflammatory state
Favorable
Nutritional resilience
Improving
Discontinuation risk
18%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events
solid = observed · dashed = predicted
  1. Day 0 META-24 started — Baseline state S20
  2. Day 23 Trajectory diverged from prediction — Observed response fell below the model's expected path.

What changed?

Trajectory began diverging from predicted response on Day 23.

Primary contributors, last 14 days
  • Nutritional resilience+6
  • Treatment adherence-4

What helped?

No interventions yet.

    LIFE OS recommendation
    No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.

    Daily trackers

    Molecule settings

    The trackers this program marks as important, last 14 days vs the 14 before.

    Active minutes
    Wearable
    37 min
    worsening · -8.4 vs previous 14 d
    Sleep duration
    Wearable
    6.8 h
    stable · -0.1 vs previous 14 d
    Energy level
    Daily log
    5.9/10
    worsening · -0.4 vs previous 14 d
    Steps
    Wearable
    3,194
    worsening · -735 vs previous 14 d
    GI burden
    Companion
    26.4/100
    worsening · +8.1 vs previous 14 d
    Adherence
    Companion
    82.1 %
    stable · -2.2 vs previous 14 d
    Sleep quality
    Wearable
    53/100
    worsening · -2.2 vs previous 14 d
    Glucose, CGM daily mean
    CGM
    129 mg/dL
    stable · +2.9 vs previous 14 d
    This trajectory is doing well — what to keep, what to watch
    Steering view →

    Heading drifting · 60 from the failing basin, 53 from restoration.

    Good elements to keep
    • Butyrate producers intact
      hidden · steering +7.5
    • Protein (supports)
      perturbation · steering +7.1
    • Histamine load (supports)
      perturbation · steering +3.8
    • Protein
      supporter · GI -4.3 next day
    • Histamine load
      supporter · GI -2.8 next day
    Main detractors to watch
    • Bacteroides fragilis elevated
      hidden · steering -7.4
    • IL6 high-expression variant
      hidden · steering -7.3
    • Alcohol
      perturbation · steering -7.2
    • Alcohol
      detractor · GI +4.7 next day
    State influencers · digestive

    Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

    • Alcohol
      +4.7detractor · 95%
    • Protein
      -4.3supporter · 95%
    • Histamine load
      -2.8supporter · 56%
    • Ultra-processed food
      +1.8no signal · 48%
    • Dietary fat load
      +0.9no signal · 22%
    • Simple carbohydrates
      +0.9no signal · 19%
    • Insoluble fibre
      -0.7no signal · 15%
    • Caffeine
      +0.6no signal · 15%

    Biological layers

    Which pathways look influenced, and by which layer of this person's biology.

    Pathways under pressure
    • Inflammatory signalling ↓45
      • DNAIL6 -174 variant raises baseline inflammatory tone
      • MicrobiomeBacteroides fragilis expansion
    • Autonomic recovery ↓45
      • WearableResting HR 73 bpm
      • Wearable3,194 steps/day
    DNA
    Fictional pharmacogenomic panel
    • IL6 -174 G/C
      Higher inflammatory tone
    • CYP2D6 Intermediate metabolizer
      Expected exposure
    Microbiome
    Shannon diversity 4.5 · butyrate capacity 57/100
    • Akkermansia muciniphilaNormal
    • Faecalibacterium prausnitziiNormal
    • Bacteroides fragilisHigh
    • Bifidobacterium longumNormal
    • EnterobacteriaceaeNormal
    Wearable, last 14 days
    daily evolution fed into the runtime
    HRV
    53 ms
    Sleep
    6.3 h
    Steps
    3,123
    Resting HR
    69 bpm
    Daily log: GI score 26, nutritional resilience 65, adherence 82.

    What this patient sees in NostraAI

    The content that steers the trajectory: what to eat, what to do, what to take.

    Open companion preview
    What to eat
    • Keep meals regular; three to four moderate portions spaced through the day
    • Include a cooked vegetable portion with each main meal
    • Keep fibre steady; no new sources this week
    • Eat slowly and stop at comfortable fullness — smaller volume, more often
    What to do
    • Log the daily check-in; one line is enough
    • A 15-minute walk after lunch
    • Keep the sleep window steady
    • Keep hydration steady: small amounts through the day rather than large volumes at once
    What to take
    • Take the dose at the same time relative to your evening meal
    • No additional supplements this week
    • Fictional demo item: continue vitamin D as before

    284 biologically similar trajectories

    Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

    Sort by similaritySort by interventionSort by outcomeSort by stateSort by response
    PatientSimilarityBaselineInterventionOutcomeResponse today
    P-0255238%S07AD-05no change29
    P-0209337%S05AD-05no change40
    P-0228532%S14AD-05no change39
    P-0203130%S12AD-05improved47
    P-0233143%S14BR-03improved34
    P-0232538%S19BR-03no change33
    P-0243938%S08BR-03no change40
    P-0252238%S01BR-03no change40
    P-0230837%S13BR-03no change27
    P-0256437%S15BR-03improved32
    P-0208732%S01BR-03no change40
    P-0263827%S01BR-03improved41